India has seen massive growth in the Ayush industry: Dr Dinesh Baruah, Central Ayurveda

economictimes.indiatimes.com:

Dinesh Baruah, Assistant Director, Central Ayurveda Research Institute (CARI) Guwahati, said that India has seen massive growth in the Ayush industry from 28.5 billion dollars in 2014 to 18.1 billion dollars in 2020. Giving a deep focus on laws, practices and regulations related to drug manufacturing and marketing.

A two-day training programme exclusively for AYUSH (Ayurveda Siddha, Unani & Homoeopathy) Drug Regulators, Drug Inspector & Drugs Laboratory Personnel for across Northeastern region has been organized by Central Ayurveda Research Institute, Guwahati. The programme was inaugurated by Dr Kousthubha Upadhayaya, Adviser (Ayurveda) Ministry of Ayush in presence of Dr Hemanta Das, Joint Director, National Ayush Mission, Government of Assam, Dr Pranabjyoti Baishya, Principal Government Ayurvedic College, Assam, Dr Ravindra Singh Assistant Director (Chemistry) Central Council for Research in Ayurvedic Sciences (CCRAS) and Dr Dinesh Baruah, Assistant Director, Central Ayurveda Research Institute (CARI), Guwahati.

Baruah, Assistant Director, Central Ayurveda Research Institute (CARI) Guwahati, said, «Our country has seen massive growth in the Ayush industry from 28.5 billion dollars in 2014 to 18.1 billion dollars in 2020.» He further revealed that there is always a challenge for drug regulators to ensure the quality standards are being followed by ASU&H drug manufacturers. «It is the duty of drug regulators and inspectors to prevent malpractices during marketing and make sure that only those drugs should be marketed which adhere to the set parameters of quality control,» he asserted.